AstrophyllineCAS# 5081-53-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 5081-53-8 | SDF | Download SDF |
| PubChem ID | 5281682 | Appearance | Powder |
| Formula | C19H26N2O | M.Wt | 298.43 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (Z)-3-phenyl-1-[(3R)-3-[(2R)-piperidin-2-yl]piperidin-1-yl]prop-2-en-1-one | ||
| SMILES | C1CCNC(C1)C2CCCN(C2)C(=O)C=CC3=CC=CC=C3 | ||
| Standard InChIKey | XIZYLQMCWHMQNP-SKFQIZJUSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Structure Identification | J Org Chem. 2003 Apr 4;68(7):2913-20.Total synthesis of (+)-astrophylline.[Pubmed: 12662069]
|
Astrophylline Dilution Calculator
Astrophylline Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.3509 mL | 16.7543 mL | 33.5087 mL | 67.0174 mL | 83.7717 mL |
| 5 mM | 0.6702 mL | 3.3509 mL | 6.7017 mL | 13.4035 mL | 16.7543 mL |
| 10 mM | 0.3351 mL | 1.6754 mL | 3.3509 mL | 6.7017 mL | 8.3772 mL |
| 50 mM | 0.067 mL | 0.3351 mL | 0.6702 mL | 1.3403 mL | 1.6754 mL |
| 100 mM | 0.0335 mL | 0.1675 mL | 0.3351 mL | 0.6702 mL | 0.8377 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Vasicinol
Catalog No.:BCN5812
CAS No.:5081-51-6
- Hellebrigenol
Catalog No.:BCN8238
CAS No.:508-79-2
- Convallatoxin
Catalog No.:BCC8155
CAS No.:508-75-8
- Rosenonolactone
Catalog No.:BCN5621
CAS No.:508-71-4
- Ouabagenin
Catalog No.:BCC8227
CAS No.:508-52-1
- N-acetylanonaine
Catalog No.:BCN2666
CAS No.:5894-74-6
- Glutinone
Catalog No.:BCN5618
CAS No.:508-09-8
- 13(18)-Oleanen-3-ol
Catalog No.:BCN5617
CAS No.:508-04-3
- Oleanolic acid
Catalog No.:BCN5616
CAS No.:508-02-1
- Soyasapogenol A
Catalog No.:BCN1433
CAS No.:508-01-0
- Polyphyllin B
Catalog No.:BCN2833
CAS No.:50773-42-7
- Polyphyllin D
Catalog No.:BCN2401
CAS No.:50773-41-6
- Hastatoside
Catalog No.:BCN6898
CAS No.:50816-24-5
- Suchilactone
Catalog No.:BCN6752
CAS No.:50816-74-5
- Ganoderic acid LM2
Catalog No.:BCN2442
CAS No.:508182-41-0
- Vortioxetine
Catalog No.:BCC2046
CAS No.:508233-74-7
- 14,15-Didehydroisoeburnamine
Catalog No.:BCN5619
CAS No.:50838-11-4
- 1,3,5,6-Tetrahydroxyxanthone
Catalog No.:BCN3453
CAS No.:5084-31-1
- Friedelanol
Catalog No.:BCN5620
CAS No.:5085-72-3
- Tetramisole HCl
Catalog No.:BCC4735
CAS No.:5086-74-8
- 1,5,6-Trihydroxy-3-methoxyxanthone
Catalog No.:BCN8121
CAS No.:50868-52-5
- Neoliquiritin
Catalog No.:BCN6663
CAS No.:5088-75-5
- Liensinine diperchlorate
Catalog No.:BCN6336
CAS No.:5088-90-4
- 1,4-Bis(2-benzoxazolyl)naphthalene
Catalog No.:BCC8423
CAS No.:5089-22-5
Total synthesis of (+)-astrophylline.[Pubmed:12662069]
J Org Chem. 2003 Apr 4;68(7):2913-20.
The first total synthesis of (+)-Astrophylline (2) has been achieved, starting from readily available enantiomerically pure (+)-(1R,4S)-4-hydroxycyclopent-2-enyl acetate (11). A novel ruthenium-catalyzed ring-closing ring-opening ring-closing metathesis of carbocyclic olefins of general type 5 was the key step, providing the stereochemically well-defined bis-piperidyl skeleton of the target molecule. A [2,3]-Wittig-Still rearrangement of 9 was also employed as the critical transformation in the stereocontrolled generation of the 1,2-trans configuration of the cyclopentene intermediate 6c. Our early synthetic efforts toward 1,2-trans cyclopentene derivatives of type 6, as well as the synthetic pathway to an optimized 13-step total synthesis of 2 (12% overall yield), are reported.
